• Latest Posts

Rigontec and its revolutionary RNA-based immunotherapeutics raise €4.8 Million

Recently Launched Company Rigontec already Raised 9,45M Euros against Cancer

BioNTech and Ganymed Pharmaceuticals Open One of the Largest Research Facilities in Germany

Affimed secures almost $30M in Financing to continue its clinical development

ADVERTISEMENT